LUCA Science pockets $9.8m Series A
LUCA Science, an Japanese developer of functional mitochondria as therapeutic agents, has raised $9.8 million in Series A financing.
1 September 2020•1 min read
LUCA Science, an Japanese developer of functional mitochondria as therapeutic agents, has raised $9.8 million in Series A financing.